Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2020 | Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas Without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study) | CANCER RESEARCH AND TREATMENT |